β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

Item
http://www.wikidata.org/entity/Q39992588
β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte deathInduction of M2 regulatory macrophages through the β2-adrenergic receptor with protection during endotoxemia and acute lung injury.IL-27 Regulates IL-18 binding protein in skin resident cellsIsoproterenol induces vascular oxidative stress and endothelial dysfunction via a Giα-coupled β2-adrenoceptor signaling pathwayCIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways.PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction.Specific α7 nicotinic acetylcholine receptor agonist ameliorates isoproterenol-induced cardiac remodeling in mice through TGF-β1/Smad3 pathway.Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart.Overview of the IL-1 family in innate inflammation and acquired immunity.Echocardiographic assessment of β-adrenoceptor stimulation-induced heart failure with reduced heart rate in mice.
P2860

β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

Item
http://www.wikidata.org/entity/Q39992588
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@en
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@nl
type
label
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@en
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@nl
prefLabel
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@en
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
β2 adrenergic activation induc ...... yocardial hypertrophy in vivo.
@en
P2093
P2860
P304
P31
P356
10.1016/J.YJMCC.2011.09.022
P433
P478
P50
P577
P5875
P698
P932